image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Primary Recommendations

Nexxen - Synergies from Amobee of US$65m vs expectation of US$50m

July 2024

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • NEXN
  • Price:
  • 247p
Regular subscribers scrutinise my write-ups meticulously, and it's fair to say they can discern my enthusiasm for a company. I categorise the companies I cover into three excitement levels: 'Oh,' 'Oh My' and 'Oh My God.' An example of an obvious standout, classified as 'Oh My God,' was Nexxen (known as Tremor at the time) in January 2021 and I immediately added the shares to Growth Portfolio 3 that month. SCSW subscribers swiftly jumped on board, and rightfully so. The shares surged from 392p to 818p in under a year, bolstered by 8 upgrades and a dual listing in the US. Like many companies I cover, Nexxen was under the radar for UK investors. It owned a video advertising DSP (demand-side platform) and was always frustrating ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Nexxen - Ballooning US political ad spend on CTV (September 2024)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW